Avanos Medical, Inc. (AVNS)

Market Cap	824.74M
Revenue (ttm)	673.30M
Net Income (ttm)	-61.80M
Shares Out	46.20M
EPS (ttm)	-1.32
PE Ratio	n/a
Forward PE	12.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	230,913
Open	18.55
Previous Close	18.71
Day's Range	17.83 - 18.55
52-Week Range	17.24 - 30.28
Beta	0.96
Analysts	Hold
Price Target	27.33 (+53.11%)
Earnings Date	May 2, 2024

About AVNS

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game R...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Joseph F. Woody
• Employees: 3,771
• Stock Exchange: NYSE
• Ticker Symbol: AVNS

Analyst Forecast

According to 4 analysts, the average rating for AVNS stock is "Hold." The 12-month stock price forecast is $27.33, which is an increase of 53.11% from the latest price.

Price Target

$27.33

(53.11% upside)

Analyst Consensus: Hold